Disproportionality analysis of quinolone safety in children using data from the FDA adverse event reporting system (FAERS)

BACKGROUND: Quinolones are widely prescribed for the treatment or prevention of infectious diseases in children. To gain further insight into quinolone-associated adverse event (AE) in children and better protect pediatric patients, continued surveillance of safety data is essential. The purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Wenqiang, Mao, Wei, Zhang, Lin, Wu, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874243/
https://www.ncbi.nlm.nih.gov/pubmed/36714649
http://dx.doi.org/10.3389/fped.2022.1069504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874243/
https://www.ncbi.nlm.nih.gov/pubmed/36714649
http://dx.doi.org/10.3389/fped.2022.1069504

Ejemplares similares